BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 29844585)

  • 1. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer.
    Cani PD; Jordan BF
    Nat Rev Gastroenterol Hepatol; 2018 Nov; 15(11):671-682. PubMed ID: 29844585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the gut microbiota on inflammation, obesity, and metabolic disease.
    Boulangé CL; Neves AL; Chilloux J; Nicholson JK; Dumas ME
    Genome Med; 2016 Apr; 8(1):42. PubMed ID: 27098727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions.
    Solas M; Milagro FI; Ramírez MJ; Martínez JA
    Curr Opin Pharmacol; 2017 Dec; 37():87-92. PubMed ID: 29107872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiome and Obesity: A Plausible Explanation for Obesity.
    Sanmiguel C; Gupta A; Mayer EA
    Curr Obes Rep; 2015 Jun; 4(2):250-61. PubMed ID: 26029487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].
    Genser L; Poitou C; Brot-Laroche É; Rousset M; Vaillant JC; Clément K; Thenet S; Leturque A
    Med Sci (Paris); 2016 May; 32(5):461-9. PubMed ID: 27225918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota in health and disease: an overview focused on metabolic inflammation.
    Nagpal R; Kumar M; Yadav AK; Hemalatha R; Yadav H; Marotta F; Yamashiro Y
    Benef Microbes; 2016; 7(2):181-94. PubMed ID: 26645350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota and mTOR signaling: Insight on a new pathophysiological interaction.
    Noureldein MH; Eid AA
    Microb Pathog; 2018 May; 118():98-104. PubMed ID: 29548696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies.
    van den Munckhof ICL; Kurilshikov A; Ter Horst R; Riksen NP; Joosten LAB; Zhernakova A; Fu J; Keating ST; Netea MG; de Graaf J; Rutten JHW
    Obes Rev; 2018 Dec; 19(12):1719-1734. PubMed ID: 30144260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregestational overweight and obesity are associated with differences in gut microbiota composition and systemic inflammation in the third trimester.
    Zacarías MF; Collado MC; Gómez-Gallego C; Flinck H; Aittoniemi J; Isolauri E; Salminen S
    PLoS One; 2018; 13(7):e0200305. PubMed ID: 30005082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity.
    Cani PD; Osto M; Geurts L; Everard A
    Gut Microbes; 2012; 3(4):279-88. PubMed ID: 22572877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.
    Bleau C; Karelis AD; St-Pierre DH; Lamontagne L
    Diabetes Metab Res Rev; 2015 Sep; 31(6):545-61. PubMed ID: 25352002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms behind the link between obesity and gastrointestinal cancers.
    Tilg H; Moschen AR
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):599-610. PubMed ID: 25194178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Gut Microbiota in the development of obesity and Diabetes.
    Baothman OA; Zamzami MA; Taher I; Abubaker J; Abu-Farha M
    Lipids Health Dis; 2016 Jun; 15():108. PubMed ID: 27317359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Dietary Lipids in Modulating Inflammation through the Gut Microbiota.
    Wisniewski PJ; Dowden RA; Campbell SC
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30626117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implication of the Gut Microbiota in Metabolic Inflammation Associated with Nutritional Disorders and Obesity.
    Rodriguez J; Olivares M; Delzenne NM
    Mol Nutr Food Res; 2021 Jan; 65(1):e1900481. PubMed ID: 33111450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota and inflammation in chronic kidney disease and their roles in the development of cardiovascular disease.
    Onal EM; Afsar B; Covic A; Vaziri ND; Kanbay M
    Hypertens Res; 2019 Feb; 42(2):123-140. PubMed ID: 30504819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between inflammation, the gut microbiota, and metabolic osteoarthritis development: studies in a rat model.
    Collins KH; Paul HA; Reimer RA; Seerattan RA; Hart DA; Herzog W
    Osteoarthritis Cartilage; 2015 Nov; 23(11):1989-98. PubMed ID: 26521745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.